To determine whether Bcl-xL expression is triggered in neutrophils upon arrival in the tumor mass or before, we compared Bcl-xL levels from healthy or tumor-bearing mice, in neutrophils extracted from the bone marrow (BMN), peripheral blood (PBN), lung (HLN) or tumors (TAN), using flow cytometry. This evidence concerns the gene BCL2L1 and neoplasm.